FdaApplication
ANDA 208328
Identifiers
- fda_app_no: ANDA208328
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2017-01-27 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;7MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;14MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;28MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;21MG | CAPSULE, EXTENDED RELEASE;ORAL |
4 products